ArticleInvestigational new drugs2022
Selinexor synergizes with azacitidine to eliminate myelodysplastic syndrome cells through p53 nuclear accumulation.
Yixuan Guo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it